These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 758787)

  • 1. Reliability of theophylline clearance in determining chronic oral dosage regimens.
    Slotfeldt ML; Johnson CE; Grambau G; Weg JG
    Am J Hosp Pharm; 1979 Jan; 36(1):66-8. PubMed ID: 758787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Chiou method for determining theophylline dosages.
    Johnson MH; Burkle WS
    Clin Pharm; 1984; 3(2):174-8. PubMed ID: 6723223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid estimation of total body clearance of theophylline in patients receiving intravenous aminophylline infusion.
    Lau AH; O'Connor T; Lam G; Lui CY; Al-Bazzaz FJ; Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):12-5. PubMed ID: 3957483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adaptation of the oral dosage of theophylline to the asthmatic child. Value of a kinetic test by the intravenous route].
    Albertini M; Lapalus P; Maurin S; Boutte P; Mariani R
    Arch Fr Pediatr; 1982 Nov; 39(9):671-5. PubMed ID: 7165461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravenous theophylline: adaptation of dosage to blood theophylline levels at admission and to clearance].
    Laaban JP; Dupeyron JP; Guyon F; Drieu L; Rochemaure J; Fabiani P
    Ann Med Interne (Paris); 1986; 137(5):415-9. PubMed ID: 3813276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theophylline: constant-rate infusion predictions.
    Mesquita CA; Sahebjami H; Imhoff T; Thomas JP; Myre SA
    Ther Drug Monit; 1984; 6(2):157-63. PubMed ID: 6740734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early estimate of theophylline clearance during intravenous infusion.
    Rizzo A; Mirabella A; Ferrara G; Mangiacavallo A; Bonanno A; Bonsignore G
    Eur J Respir Dis; 1986 Apr; 68(4):291-7. PubMed ID: 3732424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results.
    Hatton RC; Gotz VP; Robinson JD; Russell WL; Ryerson GG
    Clin Pharm; 1983; 2(4):347-52. PubMed ID: 6883961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous maintenance aminophylline dosage in patients with asthma on regular oral theophylline.
    Chang KC; Chai H; Miles-Lawrence R; Bell TD; Pinney CT
    Ann Allergy; 1982 Dec; 49(6):315-7. PubMed ID: 7149347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
    Arbab OA; Wiggins J; Ayres JG; Stableforth DE
    Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theophylline concentration following equal doses of intravenous aminophylline and oral theophylline in preterm infants.
    al-Omran A; al-Alaiyan S
    Am J Perinatol; 1997 Mar; 14(3):147-9. PubMed ID: 9259917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion from intravenous to oral dosing using sustained-release theophylline tablets.
    Stein GE; Haughey DB; Ross RJ; Vakoutis J
    Drug Intell Clin Pharm; 1982 Oct; 16(10):772-4. PubMed ID: 7140514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the ordering of serum theophylline concentrations.
    Gentry SM; Keith TD; McMillan DM; Goetter WE
    Am J Hosp Pharm; 1981 Dec; 38(12):1937-9. PubMed ID: 7325177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of theophylline in acute asthma.
    Simons FE; Simons KJ; Shapiro GG; Pierson WE; Bierman CW
    J Med; 1978; 9(1):81-90. PubMed ID: 276563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonlinear regression program to individualize oral theophylline dosage.
    Bauer LA; Black DJ; Koup JR
    Clin Pharm; 1984; 3(3):288-90. PubMed ID: 6547379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adequacy of recommended aminophylline loading doses in children.
    Maxwell-Rubin M; Paap CM; Godley PJ
    Am J Hosp Pharm; 1994 Jul; 51(13):1667-71. PubMed ID: 7942891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.
    Gupta S; Raina RK; Samotra K; Gupta KL
    Indian J Chest Dis Allied Sci; 1991; 33(1):1-8. PubMed ID: 1791015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
    Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.